Anatomy and Pathology of the Basal Ganglia
Open Access
- 1 August 1987
- journal article
- review article
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences
- Vol. 14 (S3) , 363-372
- https://doi.org/10.1017/s0317167100037756
Abstract
Neurotransmitters of the basal ganglia are of three types: I, amino acids; II, amines; and III, peptides. The amino acids generally act ionotropically while the amines and peptides generally act metabotropically. There are many examples of neurotransmitter coexistence in basal ganglia neurons. Diseases of the basal ganglia are characterized by selective neuronal degeneration. Lesions of the caudate, putamen, subthalamus and substantia nigra pars compacta occur, respectively, in chorea, dystonia, hemiballismus and parkinsonism. The differing signs and symptoms of these diseases constitute strong evidence of the functions of these various nuclei. Basal ganglia diseases can be of genetic origin, as in Huntington's chorea and Wilson's disease, of infectious origin as in Sydenham's chorea and postencephalitic parkinsonism, or of toxic origin as in MPTP poisoning. Regardless of the etiology, the pathogenesis is often regionally concentrated for reasons that are poorly understood. From studies on Parkinson and Huntington disease brains, evidence is presented that a common feature may be the expression of HLA-DR antigen on reactive microglia in the region where pathological neuronal dropout is occurring.Keywords
This publication has 40 references indexed in Scilit:
- Topography of enkephalin, substance P and acetylcholinesterase staining in Huntington's disease striatumNeuroscience Letters, 1986
- Striatal dopamine and homovanillic acid in Huntington's DiseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1986
- Dopamine D2 receptor density remains constant in treated Parkinson's diseaseAnnals of Neurology, 1986
- Adrenergic receptors on cerebral microvessels in control and Parkinsonian subjectsLife Sciences, 1985
- Transplantation of cultured fetal human adrenal chromaffin cells to rat brainNeuroscience Letters, 1985
- L-DOPA reverses the elevated density of D2 dopamine receptors in Parkinson's diseased striatumJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- Loss of high affinity neurotensin receptors in substantia nigra from parkinsonian subjectsBiochemical and Biophysical Research Communications, 1984
- Regional Distribution of Neurotransmitter Synthesizing Enzymes in the Basal Ganglia of Human BrainJournal of Neurochemistry, 1980
- Characterization of brain proteins reacting in vitro with anti-neuronal antibodies in patients with Huntington's diseaseClinical Immunology and Immunopathology, 1978
- Neurotransmitter receptor alterations in Parkinson's diseaseLife Sciences, 1977